Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,295 papers from all fields of science
Search
Sign In
Create Free Account
Ticagrelor 60 MG Oral Tablet [Brilinta]
Known as:
BRILINTA (ticagrelor) 60 MG Oral Tablet
, Brilinta 60 MG Oral Tablet
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
Magnesium stearate
Mannitol
Oral Tablet
Polyethylene Glycol 400
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Bioequivalence Study of Ticagrelor Tablet in Healthy Volunteers
A. Mungantiwar
2020
Corpus ID: 216347839
Aim: To evaluate the comparative oral bioavailability of single dose of Tigemac® Tablets 90 mg (Ticagrelormanufactured by…
Expand
Review
2017
Review
2017
Plavix and lumbar puncture
2017
Corpus ID: 33148352
Feb 3, 2016. Quincke performed the first lumbar puncture (LP) in 1891 to relieve of bleeding with thienopyridine derivatives…
Expand
2016
2016
Clinical Psychopharmacology Update: What's in a Name? Confusion Prompts Change for Vortioxetine's Brand Name
Thomas J. Tobin
,
M. Tobin
Issues in Mental Health Nursing
2016
Corpus ID: 34007506
Similar names between two unrelated drugs have led the FDA to issue warnings about and now approve a name change for vortioxetine…
Expand
2013
2013
Potential Benefits of Ticagrelor beyond Platelet Inhibition
D. W. Nilsen
The Cardiology
2013
Corpus ID: 2172126
lial dysfunction in the ticagrelor group. In the latter group, reactive hyperemia index was not correlated to age and glomerular…
Expand
2011
2011
Ticagrelor (Brilinta)--better than clopidogrel (Plavix)?
The Medical letter on drugs and therapeutics
2011
Corpus ID: 11679069
The FDA has approved ticagrelor (Brilinta-AstraZeneca), an oral antiplatelet drug, for use with low-dose aspirin to reduce the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE